Dacron femoral-popliteal bypass grafts in good-risk claudicant patients.

摘要: Abstract Purpose To evaluate prosthetic femoral-popliteal (FP) grafts as bypass conduits in favorable patients with refractory calf claudication. Setting University-affiliated urban teaching hospital. Methods Cohort study of patency 6-mm Dacron FP used to treat medically claudication meeting the following criteria: nonsmoker; above-knee popliteal artery an appropriate target vessel; ≥2-vessel tibial outflow; and postoperative anticoagulation antiplatelet therapy. End points included primary secondary graft patency, need for outcome subsequent intervention, limb amputation, survival. Results From January 1998 through March 2001, 92 underwent 100 All serial surveillance using duplex ultrasound. Using Society Vascular Surgery/International Cardiovascular Surgery criteria life-table, was 84%, assisted 88%, 90% at 5 years. Two (2%) died during a mean follow-up period 49 months (range 30 68). No limbs required amputation. Among 9 which failed, 8 successful autogenous artery. Conclusion In highly selected subjects features known increase likelihood function well. Such undergo simpler, more straightforward procedure than when is performed. Subsequent success repeat suggests that previous does not threaten lower-extremity arterial outflow.